.FDA declines experimental MDMA-assisted therapy for post-traumatic stress disorder NBC NewsF.D.A. Decreases to Authorize MDMA Therapy, Seeking Even More Research The Nyc TimesFDA Declines Ecstasy-Based Drug The Commercial JournalFDA refuses to accept unique MDMA therapy to treat post-traumatic stress disorder, along with request for more trial records CNNFDA declines to begin with experimental to alleviate post-traumatic stress disorder, requiring additional research The Washington Post.